green
Positive treatment
4.2 score
Treatment trajectory · 1999 → 2026 · click a year to view as-of
1999
2012
2026
Top citers, strongest first. 9 distinct citers.
How cited ↗
cited
Cited "see"
In Re Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Products Liability Litigation
See Barnes v. American Tobacco Co., 161 F.3d 127 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999).
discussed
Cited "see"
In re Welding Fume Products Liability Litigation
See Barnes v. American Tobacco Co., Inc., 176 F.R.D. 479, 489 (E.D.Pa.1997), affirmed, 161 F.3d 127 (3rd Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999) (observing that a court "must attempt to strike the fine balance between permissibly identifying the issues that the case will present for purposes of determining whether the requirements of Rule 23 have been met and impermissibly deciding those issues on the merits”). .
discussed
Cited "see"
Liggett Group, Inc. v. Engle
See Barnes v. American Tobacco Co., 161 F.3d 127 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999); Castano v. American Tobacco Co., 84 F.3d 734 (5th Cir.1996); Estate of Mahoney v. R.J.
cited
Cited "see"
Szczubelek v. Cendant Mortgage Corp.
See Barnes v. American Tobacco Co., 161 F.3d 127, 140 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999).
discussed
Cited "see"
In Re Rezulin Products Liability Litigation
See Barnes v. American Tobacco Co., 161 F.3d 127 , 132 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999) (court-supervised medical monitoring fund is “paradigmatic request for injunctive relief”); In re Diet Drugs, No. Civ.
cited
Cited "see"
Osgood v. Harrah's Entertainment, Inc.
See Barnes v. American Tobacco, Inc., 176 F.R.D. 479 (E.D.Pa.1997), aff'd, 161 F.3d 127 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999).
cited
Cited "see"
Miller v. Hygrade Food Products Corp.
See Barnes v. American Tobacco Co., 161 F.3d 127, 140 (3d Cir.1998), cert. denied, 526 U.S. 1114 , 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999).
discussed
Cited "see"
Philip Morris Inc. v. Angeletti
(2×)
See Barnes v. American Tobacco Co., 176 F.R.D. 479, 500 (E.D.Pa.1997), aff'd, 161 F.3d 127 (3rd Cir.1998), cert. denied, — U.S. -, 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999); see also Emig v. American Tobacco Co., 184 F.R.D. 379, 389 (D.Kan.1998).
discussed
Cited "see"
Ida Maxwell Wells v. G. Gordon Liddy, Phillip MacKin Bailley, Movant
See Khawar v. Globe Int’l, Inc., 19 Cal.4th 254 , 79 Cal.Rptr.2d 178 , 965 P.2d 696, 702 (1998) (holding that the characterization of involuntary public figure must be reserved for those individuals who satisfy both of Gertz’s supporting grounds), cert. denied, — U.S. -, 119 S.Ct. 1760 , 143 L.Ed.2d 791 (1999).
Retrieving the full opinion text from the archive…
Geotes
v.
Mississippi Board of Veterinary Medicine
v.
Mississippi Board of Veterinary Medicine
No. 98-1477.
Supreme Court of the United States.
May 17, 1999.
Published
C. A. 5th Cir. Certiorari denied.